 |
Гипербарическая оксигенация. Инозитол. Кава‑кава. Кетогенная диета для эпилепсии и других психиатрических расстройств.
|
|
|
|
ГАМК
Abdou, A. M., S. Higashiguchi, K. Horie, et al. 2006. Relaxation and immunity enhancement effects of gamma– aminobutyric acid (GABA) administration in humans. Biofactors 26(3): 201–208.
Cocito, L., A. Bianchetti, L. Bossi, et al. 1994. GABA 30 and phosphatidylserine in human photosensitivity: A pilot study. Epilepsy Research 17: 49–53.
Green, M. L., R. G. Green, and W. Santoro. 1988. Daily relaxation modifies serum and salivary immunoglobulins and psychophysiologic symptom severity. Biofeedback & Self Regulation 13: 187–199.
Loeb, C., E. Benassi, G. P. Bo, et al. 1987. Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Research 1: 209–212.
Гипербарическая оксигенация
Hopkins, R. O., L. K. Weaver, K. J. Valentine, et al. 2007. Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. American Journal of Respiratory and Critical Care Medicine 176(10): 1001–1006.
Lo, C. P., S. Y. Chen, M. C. Chou. 2007. Diffusion– tensor MR imaging for evaluation of the efficacy of hyperbaric oxygen therapy in patients with delayed neuropsychiatric syndrome caused by carbon monoxide inhalation. European Journal of Neurology 14(7): 777–782.
Инозитол
Barak, Y., J. Levine, A. Glasman, et al. 1996. Inositol treatment of Alzheimer’s disease: a double‑ blind, cross– over placebo controlled trial. Progress in europsychopharmacology and Biological Psychiatry 20(4): 729–735.
Carey, P. D., J. Warwick, B. H. Harvey, et al. 2004. Single photon emission computed tomography (SPECT) in obsessive– compulsive disorder before and after treatment with inositol. Metabolic Brain Disease 19(1–2): 125–134.
Chengappa, K. N., J. Levine, S. Gershon, et al. 2000. Inositol as an add– on treatment for bipolar depression. Bipolar Disorders 2(1): 47–55.
Fux, M., J. Levine, A. Aviv, et al. 1996. Inositol treatment of obsessive– compulsive disorder. American Journal of Psychiatry 153(9): 1219–1221.
Кава‑ кава
Attele, A. S., J. T. Xie, C. S. Yuan. 2000. Treatment of insomnia: an alternative approach.
Alternative Medicine Review 5(3): 249–259.
Basch, E., C. Ulbricht, P. Hammerness, et al. 2002. Kava monograph. Journal of Herbal Pharmacotherapy 2(4): 65–91.
Boerner, R. J., and S. Klement. 2004. Attenuation of neuroleptic– induced extrapyramidal side effects by Kava special extract WS 1490. Wiener Medizin i – sche Wochenschrift 154(21–22): 508–510.
Pittler, M. H., and E. Ernst. 2003. Kava extract for treating anxiety. Cochrane Database of Systatic Reviews Issue 1. Art. No.: CD003383. DOI: 10. 1002/14651858. CD003383.
Scherer, J. 1998. Kava– kava extract in anxiety disorders: an outpatient observational study. Advances in Therapy 15(4): 261–269.
Кетогенная диета для эпилепсии и других психиатрических расстройств.
|
|
|
Farasat, S., E. H. Kossoff, D. J. Pillas, et al. 2006. The importance of parental expectations of cognitive improvement for their children with epilepsy prior to starting the ketogenic diet. Epilepsy & Behavior 2006 8(2): 406–410.
Kossoff, E. H., L. C. Laux, R. Blackford, et al. 2008. When do seizures usually improve with the ketogenic diet? Epilepsia 49(2): 329–333.
Martinez, C. C., P. L. Pyzik, and E. H. Kossoff. 2007. Discontinuing the ketogenic diet in seizure– free children: recurrence and risk factors. Epilepsia 48(1): 187–190.
Neal, E. G., H. Chaffe, R. H. Schwartz, et al. 2008. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurology 7(6): 500–506.
Аутизм
Evangeliou, A., I. Vlachonikolis, H. Mihailidou, et al. 2003. Application of a ketogenic diet in children with autistic behavior: pilot study. Journal of Child Neurology 18(2): 113–118.
Поведение
Murphy, P., S. S. Likhodii, M. Hatamian, et al. 2005. Effect of the ketogenic diet on the activity level of Wistar rats. Pediatric Research 57(3): 353–357.
Pulsifer, M. B., J. M. Gordon, J. Brandt, et al. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Developmental Medicine & Child Neurology 43(5): 301–306.
Биполярное расстройство
El– Mallakh, R. S., and M. E. Paskitti. 2001. The ketogenic diet may have moodstabilizing properties. Medical Hypotheses 57(6): 724–726.
Yaroslavsky, Y., Z. Stahl, and R. H. Belmaker. 2002. Ketogenic diet in bipolar illness. Bipolar Disorders 4(1): 75.
Жирные кислоты омега‑ 3/рыбий жир и депрессия
Conklin, S. M., S. B. Manuck, J. K. Yao, et al. High omega–6 and low omega–3 fatty acids are associated with depressive symptoms and neuroticism. Psychosomatic Medicine 69(9): 932–934.
Grenyer, B. F., T. Crowe, B. Meyer, et al. 2007. Fish oil supplementation in the treatment of major depression: a randomised double– blind placebocontrolled trial. Progress in Neuropsychopharmacology and Biological Psychiatry 31(7): 1393–1396.
Stoll, A. L., C. A. Locke, L. B. Marangell, et al. 1999. Omega–3 fatty acids and bipolar disorder: A review. Prostaglandins, Leukotrienes & Essential Fatty Acids 60(5–6): 329–337.
Валериана
Balderer, G., and A. A. Borbely. 1985. Effect of valerian on human sleep. Psychopharmacology 87(4): 406–409.
Coxeter, P. D., P. J. Schluter, H. L. Eastwood, et al. 2003. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n– of– 1 trials. Complementary Therapies in Medicine 11(4): 215–222.
Diaper, A., and I. Hindmarch. 2004. A double– blind, placebo– controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep– disturbed older adults. Phytotherapy Research 18(10): 831–836.
Kuhlmann, J., W. Berger, H. Podzuweit, et al. 1999. The influence of valerian treatment on «reaction time, alertness and concentration» in volunteers. Pharmacopsychiatry 32(6): 235–241.
|
|
|
